Search

Search Constraints

You searched for: Author/Creator Monkhorst, Kim

Search Results

1. Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile. (2nd November 2019)

2. A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project. (May 2019)

3. Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial. Issue 3 (March 2019)

5. Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations. (10th November 2020)

6. Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancer. Issue 7 (10th December 2019)

7. The impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer. (April 2022)

8. Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis. (4th November 2021)

9. Impact of Centralization of Care for Malignant Peritoneal Mesothelioma: A historical cohort study from two Dutch expert centers. Issue 2 (February 2022)

10. Biological and technical factors in the assessment of blood-based tumor mutational burden (bTMB) in patients with NSCLC. Issue 2 (25th February 2022)